Page last updated: 2024-09-04

interleukin 1beta (193-195) and lignans

interleukin 1beta (193-195) has been researched along with lignans in 1 studies

Compound Research Comparison

Studies (interleukin 1beta (193-195))	Trials (interleukin 1beta (193-195))	Recent Studies (post-2010) (interleukin 1beta (193-195))	Studies (lignans)	Trials (lignans)	Recent Studies (post-2010) (lignans)
18	0	2	7,024	95	4,172

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Khan, IA; Moraes, RM; Pasco, DS; Pugh, N	1

Other Studies

1 other study(ies) available for interleukin 1beta (193-195) and lignans

Article	Year
Podophyllotoxin lignans enhance IL-1beta but suppress TNF-alpha mRNA expression in LPS-treated monocytes. Immunopharmacology and immunotoxicology, 2001, Volume: 23, Issue:1 Topics: Cells, Cultured; Electrophoresis, Agar Gel; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-1beta; Lignans; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Monocytes; NF-kappa B; Peptide Fragments; Podophyllotoxin; RNA, Messenger; Structure-Activity Relationship; Time Factors; Tumor Necrosis Factor-alpha	2001

Article

Year

Podophyllotoxin lignans enhance IL-1beta but suppress TNF-alpha mRNA expression in LPS-treated monocytes.

Immunopharmacology and immunotoxicology, 2001, Volume: 23, Issue:1

Topics: Cells, Cultured; Electrophoresis, Agar Gel; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-1beta; Lignans; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Monocytes; NF-kappa B; Peptide Fragments; Podophyllotoxin; RNA, Messenger; Structure-Activity Relationship; Time Factors; Tumor Necrosis Factor-alpha

2001